Successful treatment of mast cell sarcoma of the uterus with imatinib

International Journal of Hematology

Volumn 94, Issue 5, 2011, Pages 491-494

  Ma, Hong Bing ^a   Xu, Xia ^a   Liu, Wei Ping ^a   Chang, Hong ^a   Zeng, Fan ^a   Wang, Yu Chun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

C kit; Imatinib; Mast cell sarcoma

Indexed keywords

BCR ABL PROTEIN; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IMATINIB; MITOXANTRONE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; VINCRISTINE;

ABDOMINAL DISTENSION; ADULT; ARTICLE; BODY TEMPERATURE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DISTANT METASTASIS; FEMALE; HUMAN; LEUKEMIA; MULTIPLE CYCLE TREATMENT; ONCOGENE C KIT; OVARY CYST; PERITONEAL BIOPSY; PHYSICAL EXAMINATION; PROGNOSIS; TREATMENT RESPONSE; UTERUS SARCOMA;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; GENES, ABL; HUMANS; MAST-CELL SARCOMA; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 84355162931     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0952-2     Document Type: Article

References (16)

1. HP Horny MR Parwaresch E Kaiserling, et al. 1986 Mast cell sarcoma of the larynx J Clin Pathol 39: 596 602 10.1136/jcp.39.6.596 (Pubitemid 16069663)
2. M Kojima S Nakamura H Itoh, et al. 1999 Mast cell sarcoma with tissue eosinophilia arising in the ascending colon Mod Pathol 12 739 743 10430280 1:STN:280:DyaK1Mzlslenuw%3D%3D (Pubitemid 29354889)
3. PP Guenther A Huebner SB Sobottka, et al. 2001 Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy J Pediatr Hematol Oncol 23 134 138 11216707 10.1097/00043426-200102000-00014 1:STN:280:DC%2BD3M7jsFKisw%3D%3D (Pubitemid 32162678)
4. L Brcic LB Vuletic J Stepan, et al. 2007 Mast-cell sarcoma of the tibia J Clin Pathol 60 4 424 425 17405977 10.1136/jcp.2006.040857 (Pubitemid 46596565)
5. A Vega-Ruiz JE Cortes M Sever, et al. 2009 Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis Leuk Res 33 1481 1484 19193436 10.1016/j.leukres.2008.12.020 1:CAS:528:DC%2BD1MXhtVegs7vO
6. Y Hirayama Y Konuma K Kohda, et al. 2008 Systemic mastocytosis without the typical mutation of codon 816 successfully treated with imatinib Nippon Naika Gakkai Zasshi 97 2542 2545 19051746
7. A Chott P Guenther A Huebner, et al. 2003 Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma Am J Surg Pathol 27 1013 1019 12826896 10.1097/00000478-200307000-00019 (Pubitemid 36758906)
8. Horny HP, Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. p. 54-63.
9. BJ Druker F Guilhot SG O'Brien, et al. 2006 Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia N Engl J Med 355 2408 2417 17151364 10.1056/NEJMoa062867 1:CAS:528:DC%2BD28Xht12ntrzM (Pubitemid 44903745)
10. BJ Longley MJ Reguera Y Ma 2001 Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy Leuk Res 25 571 576 11377682 10.1016/S0145-2126(01)00028-5 1:CAS:528:DC%2BD3MXjslSisbg%3D (Pubitemid 32506764)
11. C Akin G Fumo AS Yavuz PE Lipsky L Neckers DD Metcalfe 2004 A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib Blood 103 3222 3225 15070706 10.1182/blood-2003-11-3816 1:CAS:528:DC%2BD2cXjsVagsb0%3D (Pubitemid 38451702)
12. MJ Frost PT Ferrao TP Hughes LK Ashman 2002 Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant Mol Cancer Ther 1 1115 1124 12481435 1:CAS:528:DC%2BD3sXmtFamsQ%3D%3D
13. K Hartmann E Wardelmann Y Ma, et al. 2005 Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis Gastroenterology 129 1042 1046 16143141 10.1053/j.gastro.2005.06.060 1:CAS:528:DC%2BD2MXhtV2isrbI (Pubitemid 41242694)
14. MC Heinrich H Joensuu GD Demetri, et al. 2008 Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases Clin Cancer Res 14 2717 2725 18451237 10.1158/1078-0432.CCR-07-4575 1:CAS:528: DC%2BD1cXlsV2qtbw%3D
15. KM Hoffmann A Moser P Lohse, et al. 2008 Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation Blood 112 1655 1657 18567837 10.1182/blood-2008-03-147785 1:CAS:528:DC%2BD1cXhtVylu77F
16. HP Horny K Sotlar P Valent 2007 Mastocytosis: state of the art Pathobiology 74 121 132 17587883 10.1159/000101711 1:CAS:528: DC%2BD2sXmvFSmsbg%3D (Pubitemid 46985284)